Finally a Scientifically Proven Treatment for Alzheimer's Disease!
Click Patient Info to find out more
Dobri Kiprov, M.D., H.P. (ASCP)
World Class Physicians
“Therapeutic Apheresis is all about education.,” said Dobri D. Kiprov, MD, in an award acceptance speech. This site is devoted to therapeutic apheresis education. Dr. Kiprov is an immunologist who has devoted his medical career to the research and development of TA and has published more than 100 articles on the subject. H e was the first physician to be board certified in hemapheresis (H.P., ASCP)
Dr. Kiprov is internationally recognized as an expert in therapeutic apheresis. He is the founder of the first mobile therapeutic apheresis program in the world which is now the model of delivery in several countries. He served two terms on the Board of Directors for the American Society for Apheresis (ASFA) and he developed the first multimedia educational program for ASFA. Currently he is a member of the Board of Directors of the International Society for Apheresis (ISFA). Dr. Kiprov has received multiple awards for his pioneering work in the field of apheresis and his educational efforts. As the Medical Director for Apheresis Care Group, he is in charge of a program that delivers more than 30,000 apheresis treatments per year. To learn more about Dr. Kiprov, please visit his site at www.DobriKiprov.com.
World Class Nurses
Ms. Rohe is a senior healthcare professional with more than 30 years of experience in the field of therapeutic apheresis. She has developed and managed several large mobile apheresis programs in the US and has received the SHS Award from the American Society For Apheresis (ASFA) for her contributions to the field of apheresis medicine. Currently, she oversees the largest apheresis program in the US, providing more than 33,000 procedures annually. She has authored several textbook chapters on apheresis for ASFA and the American Nephrology Nurses Association (ANNA), along with numerous abstracts and articles. She is frequently invited to speak at both national and international conferences about various aspects of apheresis business strategy as well as patient care topics.